SRS4566738 SAMN11309238 GSM3701033 Sham rep1 10090 Mus musculus bioproject 530225 source_name cardiac muscle strain C57BL/6JO1aHsd tissue cardiac muscle age at tx start 8-10 week experimental time point 1W+6W surgery Sham treatment None dose NA SRS4566740 SAMN11309233 GSM3701035 Sham rep3 10090 Mus musculus bioproject 530225 source_name cardiac muscle strain C57BL/6JO1aHsd tissue cardiac muscle age at tx start 8-10 week experimental time point 1W+6W surgery Sham treatment None dose NA SRS4566741 SAMN11309288 GSM3701037 MI+IgG rep2 10090 Mus musculus bioproject 530225 source_name cardiac muscle strain C57BL/6JO1aHsd tissue cardiac muscle age at tx start 8-10 week experimental time point 1W+6W surgery Permanent ligation of the LAD treatment mouse anti IgG ab dose 10mg/kg SRS4566743 SAMN11309236 GSM3701039 GEO accession GSM3701039 is currently private and is scheduled to be released on Apr 02, 2019. 10090 Mus musculus SRS4566745 SAMN11309287 GSM3701041 MI+FG-3149 rep1 10090 Mus musculus bioproject 530225 source_name cardiac muscle strain C57BL/6JO1aHsd tissue cardiac muscle age at tx start 8-10 week experimental time point 1W+6W surgery Permanent ligation of the LAD treatment mouse anti CTGF mAb (FG-3149) dose 10mg/kg SRS4566746 SAMN11309235 GSM3701040 MI+IgG rep5 10090 Mus musculus bioproject 530225 source_name cardiac muscle strain C57BL/6JO1aHsd tissue cardiac muscle age at tx start 8-10 week experimental time point 1W+6W surgery Permanent ligation of the LAD treatment mouse anti IgG ab dose 10mg/kg SRS4566748 SAMN11309284 GSM3701044 MI+FG-3149 rep4 10090 Mus musculus bioproject 530225 source_name cardiac muscle strain C57BL/6JO1aHsd tissue cardiac muscle age at tx start 8-10 week experimental time point 1W+6W surgery Permanent ligation of the LAD treatment mouse anti CTGF mAb (FG-3149) dose 10mg/kg SRS4566749 SAMN11309283 GSM3701045 MI+FG-3149 rep5 10090 Mus musculus bioproject 530225 source_name cardiac muscle strain C57BL/6JO1aHsd tissue cardiac muscle age at tx start 8-10 week experimental time point 1W+6W surgery Permanent ligation of the LAD treatment mouse anti CTGF mAb (FG-3149) dose 10mg/kg SRS4566737 SAMN11309232 GSM3701036 MI+IgG rep1 10090 Mus musculus bioproject 530225 source_name cardiac muscle strain C57BL/6JO1aHsd tissue cardiac muscle age at tx start 8-10 week experimental time point 1W+6W surgery Permanent ligation of the LAD treatment mouse anti IgG ab dose 10mg/kg SRS4566739 SAMN11309237 GSM3701034 Sham rep2 10090 Mus musculus bioproject 530225 source_name cardiac muscle strain C57BL/6JO1aHsd tissue cardiac muscle age at tx start 8-10 week experimental time point 1W+6W surgery Sham treatment None dose NA SRS4566742 SAMN11309234 GSM3701038 MI+IgG rep3 10090 Mus musculus bioproject 530225 source_name cardiac muscle strain C57BL/6JO1aHsd tissue cardiac muscle age at tx start 8-10 week experimental time point 1W+6W surgery Permanent ligation of the LAD treatment mouse anti IgG ab dose 10mg/kg SRS4566744 SAMN11309286 GSM3701042 MI+FG-3149 rep2 10090 Mus musculus bioproject 530225 source_name cardiac muscle strain C57BL/6JO1aHsd tissue cardiac muscle age at tx start 8-10 week experimental time point 1W+6W surgery Permanent ligation of the LAD treatment mouse anti CTGF mAb (FG-3149) dose 10mg/kg SRS4566747 SAMN11309285 GSM3701043 MI+FG-3149 rep3 10090 Mus musculus bioproject 530225 source_name cardiac muscle strain C57BL/6JO1aHsd tissue cardiac muscle age at tx start 8-10 week experimental time point 1W+6W surgery Permanent ligation of the LAD treatment mouse anti CTGF mAb (FG-3149) dose 10mg/kg